Abstract:The epidemiology and molecular biology of colorectal cancer are reviewed with a view to understanding their interrelationship. Risk factors for colorectal neoplasia include a positive family history, meat consumption, smoking, and alcohol consumption. Important inverse associations exist with vegetables, nonsteroidal anti-inflammatory drugs (NSAIDs), hormone replacement therapy, and physical activity. There are several molecular pathways to colorectal cancer, especially the APC (adenomatous polyposis coli)-beta-catenin-Tcf (T-cell factor; a transcriptional activator) pathway and the pathway involving abnormalities of DNA mismatch repair. These are important, both in inherited syndromes (familial adenomatous polyposis [FAP] and hereditary nonpolyposis colorectal cancer [HNPCC], respectively) and in sporadic cancers. Other less well defined pathways exist. Expression of key genes in any of these pathways may be lost by inherited or acquired mutation or by hypermethylation. The roles of several of the environmental exposures in the molecular pathways either are established (e.g., inhibition of cyclooxygenase-2 by NSAIDs) or are suggested (e.g., meat and tobacco smoke as sources of specific blood-borne carcinogens; vegetables as a source of folate, antioxidants, and inducers of detoxifying enzymes). The roles of other factors (e.g., physical activity) remain obscure even when the epidemiology is quite consistent. There is also evidence that some metabolic pathways, e.g., those involving folate and heterocyclic amines, may be modified by polymorphisms in relevant genes, e.g., MTHFR (methylenetetrahydrofolate reductase) and NAT1 (N-acetyltransferase 1) and NAT2. There is at least some evidence that the general host metabolic state can provide a milieu that enhances or reduces the likelihood of cancer progression. Understanding the roles of environmental exposures and host susceptibilities in molecular pathways has implications for screening, treatment, surveillance, and prevention.

Colorectal Cancer Epigenetics: The Role of Environmental Factors and the Search for Molecular Biomarkers

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

Noninvasive DNA Methylation Biomarkers in Colorectal Cancer: A Systematic Review.

Epigenetics of colorectal cancer: biomarker and therapeutic potential

Epigenetics and colorectal cancer

Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications

Epigenetics and Colorectal Cancer Pathogenesis

Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis

Molecular basis of epigenetic regulation in cancer diagnosis and treatment

The role of epigenetic therapies in colorectal cancer

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers.

Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures

Colorectal Cancer: Molecules and Populations

Role of Gut Microbiota in Epigenetic Regulation of Colorectal Cancer

Epigenetic changes in gastrointestinal cancers

Colorectal Cancer and the Relationship Between Genes and the Environment

Potential Diagnostic and Prognostic Implications

Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis

Colorectal Cancer: From Risk Factors to Oncogenesis

The Role of Epigenetic Modifications in Colorectal Cancer Metastasis

DNA Methylation Profiling of MYC, SMAD2/3 and DNMT3A in Colorectal Cancer